<i>Erratum</i> to: Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia

Lignende værker

• <i>Erratum</i> to: Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
  af: Srdan Verstovsek, et al.
  Udgivet: (2024-04-01)
• P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA
  af: C. Harrison, et al.
  Udgivet: (2022-06-01)
• P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFIBROSIS PATIENTS ON PACRITINIB BUT NOT BEST AVAILABLE THERAPY: PERSIST-2 LANDMARK OVERALL SURVIVAL ANALYSIS
  af: Jan Bewersdorf, et al.
  Udgivet: (2023-08-01)
• P1068: RISK-ADJUSTED SAFETY ANALYSIS OF PACRITINIB IN PATIENTS WITH MYELOFIBROSIS
  af: A. Vannucchi, et al.
  Udgivet: (2022-06-01)
• Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis
  af: Claire Harrison, et al.
  Udgivet: (2023-01-01)